)
)
XOMA Corporation Investor Relations Material
Latest events
Access the full event backlog
Slides, Transcripts, and Reports from 11,000+ public companies
Latest reports from XOMA Corporation
Access all reports
XOMA Corporation is a biotechnology company that operates primarily as a royalty aggregator. The company focuses on acquiring the economic rights to potential milestone and royalty payments associated with pre-commercial and commercial-stage therapeutic candidates. XOMA's strategy involves building a diversified portfolio of royalty interests in drugs being developed by other pharmaceutical and biotech companies. This approach allows the company to mitigate risk by spreading its investments across multiple therapeutic areas and stages of development, without bearing the costs of research and development itself. The company is headquartered in Emeryville, California, and its share are listed on the NASDAQ.
Latest articles
)
Under the Hood: AutoZone's Blueprint for Retail Excellence
An in-depth look at the largest aftermarket auto parts retailer in the U.S., its philosophy, and masterful capital allocation.
19 Dec 2024
)
Lessons from Gautam Baid: Mastering Simplicity and Compounding
Gautam Baid's journey of compounding wisdom, investing simplicity, and lifelong learning – insights to transform your financial and personal growth.
13 Dec 2024
)
Rocket Lab: Breaking Ground in Space
Rocket Lab has been one of the pioneers in the commercial aerospace industry, with numerous satellite launches and space system applications.
9 Dec 2024
Ticker symbol
XOMA
Country
🇺🇸 United States